>
BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc Share Price

$3.42 -0.1  -1.4%

Last Trade - 16/04/21

Sector
Healthcare
Size
Small Cap
Market Cap £249.4m
Enterprise Value £225.5m
Revenue £113.1m
Position in Universe 3973rd / 6850
Bullish
Bearish
Unlock BDSI Revenue
Momentum
Relative Strength (%)
1m -14.6%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -37.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
48.2 15.5 62.0 55.6 111.4 156.5 177.8 215.2 +26.5%
-2.95 +83.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,BioDelivery Sciences International, Inc. revenues increased40% to $156.5M. Net income totaled $25.7M vs. loss of$15.3M. Revenues reflect Product sales increase of 43% to$154.6M. Net Income reflects IE on Capital Financing, Grossdecrease of 63% to $7M (expense), Interest (Expense) Incomedecrease of 67% to $313K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BDSI Revenue Unlock BDSI Revenue

Net Income

BDSI Net Income Unlock BDSI Revenue

Normalised EPS

BDSI Normalised EPS Unlock BDSI Revenue

PE Ratio Range

BDSI PE Ratio Range Unlock BDSI Revenue

Dividend Yield Range

BDSI Dividend Yield Range Unlock BDSI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BDSI EPS Forecasts Unlock BDSI Revenue
Profile Summary

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company's products utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved products BUNAVAIL (buprenorphine and naloxone buccal film) buccal film and BELBUCA (buprenorphine) buccal film, utilize BEMA technology.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated April 18, 2002
Public Since June 25, 2002
No. of Shareholders: 110
No. of Employees: 176
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 100,861,848
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BDSI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BDSI
Upcoming Events for BDSI
Wednesday 5th May, 2021 Estimate
Q1 2021 BioDelivery Sciences International Inc Earnings Release
Friday 23rd July, 2021 Estimate
BioDelivery Sciences International Inc Annual Shareholders Meeting
Tuesday 3rd August, 2021 Estimate
Q2 2021 BioDelivery Sciences International Inc Earnings Release
Frequently Asked Questions for BioDelivery Sciences International Inc
What is the BioDelivery Sciences International Inc share price?

As of 16/04/21, shares in BioDelivery Sciences International Inc are trading at $3.42, giving the company a market capitalisation of £249.4m. This share price information is delayed by 15 minutes.

How has the BioDelivery Sciences International Inc share price performed this year?

Shares in BioDelivery Sciences International Inc are currently trading at $3.42 and the price has moved by -16.89% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioDelivery Sciences International Inc price has moved by -42.71% over the past year.

What are the analyst and broker recommendations for BioDelivery Sciences International Inc?

Of the analysts with advisory recommendations for BioDelivery Sciences International Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for BioDelivery Sciences International Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will BioDelivery Sciences International Inc next release its financial results?

BioDelivery Sciences International Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the BioDelivery Sciences International Inc dividend yield?

BioDelivery Sciences International Inc does not currently pay a dividend.

Does BioDelivery Sciences International Inc pay a dividend?

BioDelivery Sciences International Inc does not currently pay a dividend.

When does BioDelivery Sciences International Inc next pay dividends?

BioDelivery Sciences International Inc does not currently pay a dividend.

How do I buy BioDelivery Sciences International Inc shares?

To buy shares in BioDelivery Sciences International Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of BioDelivery Sciences International Inc?

Shares in BioDelivery Sciences International Inc are currently trading at $3.42, giving the company a market capitalisation of £249.4m.

Where are BioDelivery Sciences International Inc shares listed? Where are BioDelivery Sciences International Inc shares listed?

Here are the trading details for BioDelivery Sciences International Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: BDSI
What kind of share is BioDelivery Sciences International Inc?

Based on an overall assessment of its quality, value and momentum, BioDelivery Sciences International Inc is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a BioDelivery Sciences International Inc share price forecast 2021?

Shares in BioDelivery Sciences International Inc are currently priced at $3.42. At that level they are trading at 0.107% discount to the analyst consensus target price of 0.00.

Analysts covering BioDelivery Sciences International Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.29 for the next financial year.

How can I tell whether the BioDelivery Sciences International Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioDelivery Sciences International Inc. Over the past six months, the relative strength of its shares against the market has been -23.84%. At the current price of $3.42, shares in BioDelivery Sciences International Inc are trading at -15.56% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the BioDelivery Sciences International Inc PE Ratio?

The BioDelivery Sciences International Inc PE ratio based on its reported earnings over the past 12 months is 11.45. The shares are currently trading at $3.42.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of BioDelivery Sciences International Inc?

BioDelivery Sciences International Inc's management team is headed by:

Mark Sirgo - VCH
Scott Plesha - PRE
Todd Davis - IND
Kevin Kotler - IND
Peter Greenleaf - CHM
William Watson - IND
Thomas Smith - OTH
James Vollins - CCO
Mary Coelho - CFO
Joseph Lockhart - SVP
Kevin Ostrander - SVP
Jeffrey Bailey - CEO
Vanila Singh - IND
Who are the major shareholders of BioDelivery Sciences International Inc?

Here are the top five shareholders of BioDelivery Sciences International Inc based on the size of their shareholding:

Deerfield Management Company, L.P. Hedge Fund
Percentage owned: 9.45% (9.53m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 7.08% (7.14m shares)
Nantahala Capital Management, LLC Hedge Fund
Percentage owned: 5.08% (5.12m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 4.77% (4.81m shares)
Wasatch Global Investors Inc Investment Advisor/Hedge Fund
Percentage owned: 4.54% (4.58m shares)
Similar to BDSI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.